NPI 1609284249: Open Payments
NPI 1609284249. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$74 in 1 payment from 1 company in 2025. Trend: 2023 $0 · 2024 $117 · 2025 $74
Food & beverage: $74
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $74 |
Products named: REXULTI.
